Skip to main content

ORIGINAL RESEARCH article

Front. Med.
Sec. Intensive Care Medicine and Anesthesiology
Volume 11 - 2024 | doi: 10.3389/fmed.2024.1518129

Predictive Model for Assessing the Prognosis of Rhabdomyolysis Patients in the Intensive Care Unit

Provisionally accepted
Yaxin Xiong Yaxin Xiong 1Hongyu Shi Hongyu Shi 1Jianpeng Wang Jianpeng Wang 1Quankuan Gu Quankuan Gu 1Yu Song Yu Song 1Weilan Kong Weilan Kong 1Jun Lyu Jun Lyu 2*Mingyan Zhao Mingyan Zhao 1*Xianglin Meng Xianglin Meng 1*
  • 1 First Affiliated Hospital of Harbin Medical University, Harbin, China
  • 2 First Affiliated Hospital of Jinan University, Guangzhou, Guangdong Province, China

The final, formatted version of the article will be published soon.

    Background: Rhabdomyolysis (RM) frequently gives rise to diverse complications, ultimately leading to an unfavorable prognosis for patients.Consequently, there is a pressing need for early prediction of survival rates among RM patients, yet reliable and effective predictive models are currently scarce.All data utilized in this study were sourced from the MIMIC-IV database. A multivariable Cox regression analysis was conducted on the data, and the performance of the new model was evaluated based on the Harrell's concordance index (C-index) and the area under the receiver operating characteristic curve (AUC). Furthermore, the clinical utility of the predictive model was assessed through decision curve analysis (DCA).Results: A total of 725 RM patients admitted to the intensive care unit (ICU) were included in the analysis, comprising 507 patients in the training cohort and 218 patients in the testing cohort. For the development of the predictive model, 37 variables were carefully selected. Multivariable Cox regression revealed that age, phosphate max, RR mean, and SOFA score were independent predictors of survival outcomes in RM patients. In the training cohort, the AUCs of the new model for predicting 28-day, 60-day, and 90-day survival rates were 0.818 (95% CI: 0.766-0.871), 0.810 (95% CI: 0.761-0.855), and 0.819 (95% CI: 0.773-0.864), respectively. In the validation cohort, the AUCs of the new model for predicting 28-day, 60-day, and 90-day survival rates were 0.840 (95% CI: 0.772-0.900), 0.842 (95% CI: 0.780-0.899), and 0.842 (95% CI: 0.779-0.897), respectively.This study identified crucial demographic factors, vital signs, and laboratory parameters associated with RM patient prognosis and utilized them to develop a more accurate and convenient prognostic prediction model for assessing 28-day, 60-day, and 90-day survival rates.This study specifically targets patients with RM admitted to ICU and presents a novel clinical prediction model that surpasses the conventional SOFA score. By integrating specific prognostic indicators tailored to RM, the model significantly enhances prediction accuracy, thereby enabling a more targeted and effective approach to managing RM patients.

    Keywords: Rhabdomyolysis, Intensive Care Unit, prognosis, nomogram, Model

    Received: 28 Oct 2024; Accepted: 16 Dec 2024.

    Copyright: © 2024 Xiong, Shi, Wang, Gu, Song, Kong, Lyu, Zhao and Meng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Jun Lyu, First Affiliated Hospital of Jinan University, Guangzhou, 510630, Guangdong Province, China
    Mingyan Zhao, First Affiliated Hospital of Harbin Medical University, Harbin, China
    Xianglin Meng, First Affiliated Hospital of Harbin Medical University, Harbin, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.